UNI HEALTH (02211) releases its interim performance with a loss of 7.7 million yuan, a year-on-year decrease of 63.16%.
(02211) released its performance for the six months ended December 31, 2024. During this period, the group achieved...
UNI HEALTH (02211) announced its financial results for the six-month period ending on December 31, 2024. The group recorded a revenue of 441 million yuan, a decrease of 25.4% compared to the same period last year. The group suffered a loss of 7.7 million yuan, with a decrease of 63.16% compared to the same period last year. Basic loss per share was 1 cent.
The announcement stated that the decrease in the group's losses was mainly attributed to the measures taken by the group to strengthen control over various operating costs, in order to increase the company's profitability and improve future operating cash flow, thus enhancing operational efficiency. During the period, the group has closed several unprofitable retail stores in order to minimize operational losses.
Related Articles

China Longyuan Power Group Corporation (00916) completed the issuance of 2.2 billion yuan worth of ultra-short-term financing bonds.

US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) soared more than 1%, with news that NVIDIA Corporation has placed additional orders for H200 chips.

ORANGE TOUR (08627): Fan Li appointed as independent non-executive director.
China Longyuan Power Group Corporation (00916) completed the issuance of 2.2 billion yuan worth of ultra-short-term financing bonds.

US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) soared more than 1%, with news that NVIDIA Corporation has placed additional orders for H200 chips.

ORANGE TOUR (08627): Fan Li appointed as independent non-executive director.






